Should You Buy, Hold, or Sell GILD Stock Ahead of Q1 Earnings?

Biotech bigwig Gilead Sciences, Inc. GILD  is scheduled to report first-quarter 2025 results on April 24, after market close. The Zacks Consensus Estimate for sales and earnings is pegged at $6.83 billion and $1.73 per share, respectively.Earnings estimate for 2025 has increased to $7.86 from $7.80 per share over the...